Sentinel Oncology-preview

Sentineloncology

Sentinel Oncology

Private

CambridgeHealthcare & Life Scienceshttps://www.sentineloncology.com/

Last Round

Grant

Apr 1, 2018

Total Funding Raised

$10.27M

Momentum Score

50 /100

Company Overview

Sentinel Oncology is a biotechnology company that develops and commercializes new therapeutics for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug discoverysmall molecule drugsoncology therapeuticsdrug licensingbiotechChk1 inhibitorbrain cancer therapeuticsblood-brain barrier penetrationpreclinical drug developmentselective kinase inhibitorsmedicinal chemistrybrain metastasesPLK1 inhibitorS6K1 inhibitortriple-negative breast cancerFragile X syndrome

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sentinel Oncology Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sentinel Oncology Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 1, 2018
Grant	Aug 4, 2017
Grant	Aug 8, 2015
Grant	Oct 31, 2013
Grant	Apr 19, 2011
Grant	Jan 1, 2008

View all Funding Rounds

Sentinel Oncology Investors

Notable investors and investment history

Investor	Rounds
Eurostars SME programme	Grant
Biomedical Catalyst	Grant
Cambridge Enterprise Seed Funds	Seed
Innovate UK	Grant
Medical Research Council	Grant
Wellcome Trust	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 16, 2026
Monthly visitors grew 41% MoM.
Jul 5, 2025
Monthly visitors increased 119% MoM.

View all signals

Sentinel Oncology Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Sentinel Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sentinel Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge

Employee Range9

Year Founded2005

Last FundingApr 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.